Glaukos (GKOS) Net Income towards Common Stockholders (2014 - 2026)

Glaukos' (GKOS) quarterly Net Income towards Common Stockholders came in at -$19.8 million in Q1 2026, down 9.11% year-on-year from -$21.8 million in Q1 2025, and up 85.76% on a QoQ basis from -$139.0 million in Q4 2025.

Glaukos (GKOS) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Net Income towards Common Stockholders data on file, last reported at -$19.8 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 9.11% year-over-year to -$19.8 million in Q1 2026; TTM through Mar 2026 was -$194.7 million, a 57.46% decrease from a year earlier, with the FY2025 full-year figure at -$193.0 million, down 31.88% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$19.8 million, up from -$139.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for GKOS reached as high as $5.4 million in Q1 2022 and fell as low as -$139.0 million in Q4 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$35.0 million across 5 years, with a median of -$32.8 million in 2023.
  • Across the five-year window, Net Income towards Common Stockholders soared 132.81% in 2022 and slumped 740.87% in 2023, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$34.3 million in 2022, then decreased by 7.0% to -$36.8 million in 2023, then grew by 8.63% to -$33.6 million in 2024, then sank by 313.96% to -$139.0 million in 2025, then surged by 85.76% to -$19.8 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$19.8 million in Q1 2026, -$139.0 million in Q4 2025, and -$16.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Glaukos 8.79 Bn 8.68 Bn 117.23 Mn -19.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.80 Mn
Dec 31, 2025 -139.01 Mn
Sep 30, 2025 -16.23 Mn
Jun 30, 2025 -19.66 Mn
Mar 31, 2025 -18.15 Mn
Dec 31, 2024 -33.58 Mn
Sep 30, 2024 -21.41 Mn
Jun 30, 2024 -50.51 Mn
Mar 31, 2024 -40.84 Mn
Dec 31, 2023 -36.75 Mn
Sep 30, 2023 -30.44 Mn
Jun 30, 2023 -32.81 Mn
Mar 31, 2023 -34.63 Mn
Dec 31, 2022 -34.35 Mn
Sep 30, 2022 -27.53 Mn
Jun 30, 2022 -45.54 Mn
Mar 31, 2022 5.40 Mn
Dec 31, 2021 -21.87 Mn
Sep 30, 2021 6.23 Mn
Jun 30, 2021 -17.48 Mn